TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

September 10, 2026

Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market

September 10, 2026

MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

September 10, 2026

Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market

September 10, 2026

From BioMedWire

Via GlobeNewswire

The Quest to Repair What Multiple Sclerosis Takes Away

June 24, 2026

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

June 24, 2026

Given the proper catalyst, the short interest in these stocks may lead to a short squeeze. All the market needs is a push and it may come at any time.

The Most Shorted Stocks in June: Hold, Short, or Squeeze?

June 18, 2024

Via MarketBeat

TG Therapeutics Stock 300% Rally Has Legs Yet

February 08, 2023

There's further upside in the region of 30% yet to be realized, which should be more than enough to get even the more risk averse investor interested.

Via MarketBeat

The Quest to Repair What Multiple Sclerosis Takes Away

June 24, 2026

From BioMedWire

Via GlobeNewswire

TG Therapeutics, Inc. (NASDAQ:TGTX) Long Term Investor Alert: Investigation of Potential Wrongdoing ↗

November 03, 2022

San Diego, CA -- (SBWIRE) -- 11/03/2022 -- Certain directors of TG Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

June 11, 2024

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

Via FinancialNewsMedia

Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds TG Therapeutics, Inc. (TGTX) Investors of Class Action and Last Few Hours to Actively Participate

September 16, 2022

From Bronstein, Gewirtz & Grossman, LLC

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

June 11, 2024

From FN Media Group LLC

Via GlobeNewswire

TG THERAPEUTICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. and Encourages Investors to Contact the Firm

September 14, 2022

From Bragar Eagel & Squire, P.C.

TGTX FRIDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

September 11, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Topics Lawsuit

August 27, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NASDAQ:TGTX Investor Alert: Lawsuit Alleges Securities Laws Violations by TG Therapeutics, Inc. ↗

Topics Lawsuit

August 17, 2022

San Diego, CA -- (SBWIRE) -- 08/17/2022 -- An investor, who purchased shares of TG Therapeutics, Inc. (NASDAQ:TGTX), filed a lawsuit in the over alleged violations of Federal Securities Laws by TG...

Via SBWire

TOP RANKED ROSEN LAW FIRM Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

August 12, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Topics Lawsuit

August 07, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

TGTX Shareholder News: Robbins LLP is Investigating TG Therapeutics, Inc. (TGTX) on Behalf of Shareholders

Topics Lawsuit

August 01, 2022

From Robbins LLP

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

July 31, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Bronstein, Gewirtz & Grossman, LLC Notifies TG Therapeutics, Inc. (TGTX) Investors of Class Action and Encourages Investors to Contact the Firm

Topics Lawsuit

July 27, 2022

From Bronstein, Gewirtz & Grossman, LLC

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

July 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

TGTX Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX)

Topics Lawsuit

July 22, 2022

From Robbins LLP

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against TG Therapeutics, Inc. (TGTX)

July 20, 2022

From Robbins LLP

TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. and Encourages Investors to Contact the Firm

July 19, 2022

From Bragar Eagel & Squire, P.C.

INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 19, 2022

From The Schall Law Firm

SHAREHOLDER ACTON NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 18, 2022

From The Schall Law Firm

EQUITY ALERT: Rosen Law Firm Encourages TG Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TGTX

July 18, 2022

From The Rosen Law Firm, P.A.